Genetics of microtia and associated syndromes
F Alasti, G Van Camp - Journal of medical genetics, 2009 - jmg.bmj.com
Microtia is a congenital anomaly, characterised by a small, abnormally shaped auricle
(pinna). It is usually accompanied by a narrow, blocked or absent ear canal. Microtia can …
(pinna). It is usually accompanied by a narrow, blocked or absent ear canal. Microtia can …
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
MM Schoels, D Aletaha, F Alasti… - Annals of the rheumatic …, 2016 - ard.bmj.com
Background The Disease Activity Index for Psoriatic Arthritis (DAPSA) is a valid and
discriminative tool. Definitions of disease activity states and therapeutic response are still …
discriminative tool. Definitions of disease activity states and therapeutic response are still …
[HTML][HTML] Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials
D Aletaha, F Alasti, JS Smolen - Arthritis research & therapy, 2015 - Springer
Introduction Although the prognostic value of rheumatoid factor (RF) and autoantibodies
against citrullinated proteins (ACPAs) in patients with rheumatoid arthritis (RA) is well …
against citrullinated proteins (ACPAs) in patients with rheumatoid arthritis (RA) is well …
Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression
D Aletaha, F Alasti, JS Smolen - Annals of the rheumatic diseases, 2017 - ard.bmj.com
Background Recently, disease activity states were developed for the Disease Activity index
for PSoriatic Arthritis (DAPSA). Here, we assess if different DAPSA disease activity states are …
for PSoriatic Arthritis (DAPSA). Here, we assess if different DAPSA disease activity states are …
Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point
D Aletaha, F Alasti, JS Smolen - Annals of the rheumatic diseases, 2016 - ard.bmj.com
Background Treat-to-target (T2T) is a widely accepted management strategy for rheumatoid
arthritis (RA) with a key decision point at 3 months after treatment initiation. At this time point …
arthritis (RA) with a key decision point at 3 months after treatment initiation. At this time point …
Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity
D Aletaha, F Alasti, JS Smolen - Annals of the rheumatic diseases, 2013 - ard.bmj.com
Background Rheumatoid factor (RF) is prototypic for rheumatoid arthritis (RA) and serves
diagnostic and prognostic purposes. RF is associated with joint destruction, but the role of …
diagnostic and prognostic purposes. RF is associated with joint destruction, but the role of …
[PDF][PDF] A mutation in HOXA2 is responsible for autosomal-recessive microtia in an Iranian family
Microtia, a congenital deformity manifesting as an abnormally shaped or absent external
ear, occurs in one out of 8,000–10,000 births. We ascertained a consanguineous Iranian …
ear, occurs in one out of 8,000–10,000 births. We ascertained a consanguineous Iranian …
[HTML][HTML] Evaluation of newly proposed remission cut-points for disease activity score in 28 joints (DAS28) in rheumatoid arthritis patients upon IL-6 pathway inhibition
M Schoels, F Alasti, JS Smolen, D Aletaha - Arthritis research & therapy, 2017 - Springer
Background Stringent remission criteria are crucial in rheumatoid arthritis (RA) assessment.
Disease activity score in 28 joints (DAS28)-remission has not been included among …
Disease activity score in 28 joints (DAS28)-remission has not been included among …
[HTML][HTML] Risk profiling for a refractory course of rheumatoid arthritis
M Bécède, F Alasti, I Gessl, L Haupt… - Seminars in arthritis and …, 2019 - Elsevier
Background Despite modern therapeutics and treatment strategies, a subset of rheumatoid
arthritis (RA) patients remains insufficiently responsive to multiple therapies. Here, we …
arthritis (RA) patients remains insufficiently responsive to multiple therapies. Here, we …
American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision
Objective In 2011, the American College of Rheumatology (ACR) and EULAR endorsed
provisional criteria for remission in rheumatoid arthritis (RA), both Boolean-based and index …
provisional criteria for remission in rheumatoid arthritis (RA), both Boolean-based and index …